fluorobenzenes has been researched along with Aortic Valve Stenosis in 19 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 8 (42.11) | 29.6817 |
| 2010's | 11 (57.89) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Capoulade, R; Chan, KL; Clavel, MA; Côté, N; Després, JP; Dumesnil, JG; Mathieu, P; Pibarot, P; Tam, JW; Teo, KK | 1 |
| Capoulade, R; Chan, KL; Clavel, MA; Côté, N; Després, JP; Dumesnil, JG; Fournier, D; Mathieu, P; Pibarot, P; Tam, JW; Teo, KK | 1 |
| Erdmann, E; Hoppe, UC | 1 |
| Pedersen, TR | 1 |
| Bhagirath, KM; Chan, KL; Dumesnil, JG; Giannoccaro, PJ; Jassal, DS; Joyner, CD; Jue, J; Pandey, AS; Sochowski, RA; Tam, JW; Teo, KK | 1 |
| Paraskevas, KI | 1 |
| Chan, KL; Dumesnil, JG; Ni, A; Tam, J; Teo, K | 2 |
| Cannata, A; Martinelli, L; Russo, CF | 1 |
| Bhagirath, KM; Chan, KL; Dumesnil, JG; Jassal, DS; Karlstedt, E; Tam, JW; Teo, KK; Zeglinski, M | 1 |
| Budts, W; Cuypers, JA; Lindemans, J; Mulder, BJ; Pieper, PG; Roos-Hesselink, JW; Takkenberg, JJ; van der Burgh, PH; van der Linde, D; van Dijk, AP; Witsenburg, M; Yap, SC | 1 |
| Rosenhek, R | 1 |
| Barros, IM; Kristensen, SD; Moura, LM; Pinto, FJ; Ramos, SF; Rocha-Gonçalves, F | 1 |
| Azevedo, LF; Barros, IM; Moura, LM; Rajamannan, NM; Ramos, SF; Rocha-Gonçalves, F; Zamorano, JL | 1 |
| Chan, KL; Dumesnil, JG; Tam, J; Teo, K | 1 |
| Fuller, SH; Merz, T | 1 |
| Rahimtoola, SH | 1 |
| Chan, KL; Dumesnil, JG; Giannoccaro, PJ; Jassal, DS; Joyner, CD; Jue, J; Pandey, AS; Tam, JW; Teo, KK | 1 |
3 review(s) available for fluorobenzenes and Aortic Valve Stenosis
| Article | Year |
|---|---|
[Cardiology 2008].
Topics: Anticholesteremic Agents; Antihypertensive Agents; Aortic Valve Stenosis; Cardiac Catheterization; Cardiovascular Diseases; Drug Therapy, Combination; Electrocardiography; Fluorobenzenes; Heart Failure; Heart Valve Prosthesis Implantation; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Hypertension; Myocardial Infarction; Platelet Aggregation Inhibitors; Pyrimidines; Randomized Controlled Trials as Topic; Rosuvastatin Calcium; Sulfonamides | 2008 |
[Almanac 2011: Valvular heart disease. Review of select studies that have driven recent advances in clinical cardiology: in the care of the Editors' Network Task Force of the European Society of Cardiology].
Topics: Age Factors; Almanacs as Topic; Aortic Valve Insufficiency; Aortic Valve Stenosis; Austria; Biomarkers; Biomedical Research; Cardiac Surgical Procedures; Cardiology; Endocarditis; Fluorobenzenes; Heart Valve Diseases; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Mitral Valve Insufficiency; Natriuretic Agents; Natriuretic Peptide, Brain; Periodicals as Topic; Prevalence; Prognosis; Pyrimidines; Randomized Controlled Trials as Topic; Risk Factors; Rosuvastatin Calcium; Severity of Illness Index; Smoking; Sulfonamides; Tricuspid Valve Insufficiency | 2012 |
The year in valvular heart disease.
Topics: Animals; Aortic Valve; Aortic Valve Insufficiency; Aortic Valve Stenosis; Arabidopsis Proteins; Bioprosthesis; Body Surface Area; Catheterization; Cholesterol, LDL; Coronary Disease; Disease Progression; Echocardiography, Three-Dimensional; Endocarditis, Bacterial; Fluorobenzenes; Heart Valve Diseases; Heart Valve Prosthesis; Heart Valve Prosthesis Implantation; Hospital Mortality; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Mitral Valve Insufficiency; Mitral Valve Stenosis; Odds Ratio; Practice Guidelines as Topic; Prosthesis Design; Prosthesis Fitting; Pyrimidines; Rosuvastatin Calcium; Sulfonamides; Tomography, X-Ray Computed; Treatment Outcome; Tricuspid Valve Insufficiency; Ventricular Dysfunction, Left | 2008 |
11 trial(s) available for fluorobenzenes and Aortic Valve Stenosis
| Article | Year |
|---|---|
Insulin resistance and LVH progression in patients with calcific aortic stenosis: a substudy of the ASTRONOMER trial.
Topics: Adult; Aged; Aortic Valve; Aortic Valve Stenosis; Calcinosis; Canada; Chi-Square Distribution; Disease Progression; Female; Fluorobenzenes; Hemodynamics; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertrophy, Left Ventricular; Insulin Resistance; Linear Models; Logistic Models; Male; Middle Aged; Multivariate Analysis; Prospective Studies; Pyrimidines; Risk Assessment; Risk Factors; Rosuvastatin Calcium; Severity of Illness Index; Sulfonamides; Time Factors; Ultrasonography; Ventricular Function, Left; Ventricular Remodeling | 2013 |
Circulating levels of matrix gla protein and progression of aortic stenosis: a substudy of the Aortic Stenosis Progression Observation: Measuring Effects of rosuvastatin (ASTRONOMER) trial.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aortic Valve Stenosis; Calcium-Binding Proteins; Disease Progression; Echocardiography, Doppler; Extracellular Matrix Proteins; Female; Fluorobenzenes; Humans; Male; Matrix Gla Protein; Middle Aged; Multivariate Analysis; Prospective Studies; Pyrimidines; Rosuvastatin Calcium; Sulfonamides | 2014 |
Association of Bicuspid aortic valve morphology and aortic root dimensions: a substudy of the aortic stenosis progression observation measuring effects of rosuvastatin (ASTRONOMER) study.
Topics: Aortic Valve; Aortic Valve Stenosis; Female; Fluorobenzenes; Humans; Male; Middle Aged; Pyrimidines; Rosuvastatin Calcium; Statistics as Topic; Sulfonamides; Treatment Outcome; Ultrasonography | 2010 |
Effect of Lipid lowering with rosuvastatin on progression of aortic stenosis: results of the aortic stenosis progression observation: measuring effects of rosuvastatin (ASTRONOMER) trial.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aortic Valve Stenosis; Cholesterol; Disease Progression; Double-Blind Method; Electrocardiography; Female; Fluorobenzenes; Follow-Up Studies; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lipid Metabolism; Lipids; Male; Middle Aged; Pyrimidines; Rosuvastatin Calcium; Sulfonamides; Treatment Failure; Young Adult | 2010 |
Evaluating the effectiveness of rosuvastatin in preventing the progression of diastolic dysfunction in aortic stenosis: A substudy of the aortic stenosis progression observation measuring effects of rosuvastatin (ASTRONOMER) study.
Topics: Adult; Aged; Aortic Valve Stenosis; Disease Progression; Echocardiography, Doppler; Female; Fluorobenzenes; Follow-Up Studies; Heart Failure, Diastolic; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Multicenter Studies as Topic; Pyrimidines; Rosuvastatin Calcium; Severity of Illness Index; Sulfonamides | 2011 |
Effects of rosuvastatin on progression of stenosis in adult patients with congenital aortic stenosis (PROCAS Trial).
Topics: Adolescent; Adult; Aortic Valve; Aortic Valve Stenosis; Belgium; Blood Flow Velocity; Calcinosis; Disease Progression; Double-Blind Method; Echocardiography, Doppler; Female; Fluorobenzenes; Follow-Up Studies; Heart Valve Prosthesis; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Natriuretic Peptide, Brain; Netherlands; Peptide Fragments; Prospective Studies; Pyrimidines; Rosuvastatin Calcium; Sulfonamides; Young Adult | 2011 |
Effect of rosuvastatin on C-reactive protein and progression of aortic stenosis.
Topics: Adult; Aged; Aortic Valve Stenosis; Body Mass Index; C-Reactive Protein; Disease Progression; Female; Fluorobenzenes; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Pyrimidines; Rosuvastatin Calcium; Sulfonamides | 2011 |
Rosuvastatin slows the development of diastolic dysfunction in calcific aortic stenosis.
Topics: Aged; Aged, 80 and over; Aortic Valve Stenosis; Calcinosis; Diastole; Disease Progression; Echocardiography; Female; Fluorobenzenes; Follow-Up Studies; Heart Failure, Diastolic; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Natriuretic Peptide, Brain; Prospective Studies; Pyrimidines; Rosuvastatin Calcium; Sulfonamides; Treatment Outcome; Ventricular Dysfunction, Left | 2012 |
Rosuvastatin affecting aortic valve endothelium to slow the progression of aortic stenosis.
Topics: Aged; Aged, 80 and over; Aortic Valve; Aortic Valve Stenosis; Blood Flow Velocity; C-Reactive Protein; CD40 Antigens; Cohort Studies; Echocardiography; Female; Fluorobenzenes; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Interleukin-6; Lipids; Male; Pyrimidines; Rosuvastatin Calcium; Severity of Illness Index; Sulfonamides; Treatment Outcome | 2007 |
Rationale, design, and baseline characteristics of a randomized trial to assess the effect of cholesterol lowering on the progression of aortic stenosis: the Aortic Stenosis Progression Observation: Measuring Effects of Rosuvastatin (ASTRONOMER) trial.
Topics: Adult; Aged; Aged, 80 and over; Anticholesteremic Agents; Aortic Valve; Aortic Valve Stenosis; Disease Progression; Double-Blind Method; Echocardiography; Female; Fluorobenzenes; Follow-Up Studies; Heart Valve Prosthesis; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Patient Selection; Pyrimidines; Randomized Controlled Trials as Topic; Research Design; Rosuvastatin Calcium; Sulfonamides; Survival Rate; Treatment Outcome | 2007 |
Clinical usefulness of tissue Doppler imaging in patients with mild to moderate aortic stenosis: a substudy of the aortic stenosis progression observation measuring effects of rosuvastatin study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aortic Valve Stenosis; Echocardiography, Doppler; Female; Fluorobenzenes; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Prognosis; Pyrimidines; Reproducibility of Results; Rosuvastatin Calcium; Sensitivity and Specificity; Sulfonamides; Treatment Outcome; Ventricular Dysfunction, Left; Young Adult | 2008 |
5 other study(ies) available for fluorobenzenes and Aortic Valve Stenosis
| Article | Year |
|---|---|
Intensive lipid-lowering therapy for patients with aortic stenosis.
Topics: Aortic Valve Stenosis; Atorvastatin; Clinical Trials as Topic; Disease Progression; Fatty Acids, Monounsaturated; Fluorobenzenes; Fluvastatin; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypolipidemic Agents; Indoles; Pyrimidines; Pyrroles; Rosuvastatin Calcium; Simvastatin; Sulfonamides | 2008 |
Prescribing statins in aortic stenosis: little to lose, much to gain.
Topics: Aortic Valve Stenosis; Disease Progression; Fluorobenzenes; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Pyrimidines; Rosuvastatin Calcium; Sulfonamides | 2010 |
Relationship between bicuspid aortic valve morphology and aortic wall degeneration: further evidence is emerging.
Topics: Aortic Valve; Aortic Valve Stenosis; Female; Fluorobenzenes; Humans; Male; Middle Aged; Pyrimidines; Rosuvastatin Calcium; Statistics as Topic; Sulfonamides; Treatment Outcome; Ultrasonography | 2010 |
Statins for aortic valve narrowing?
Topics: Aortic Valve Stenosis; Calcinosis; Fluorobenzenes; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Pyrimidines; Rosuvastatin Calcium; Sulfonamides | 2007 |
Elevated serum transaminase levels resulting from concomitant use of rosuvastatin and amiodarone.
Topics: Aged; Alanine Transaminase; Amiodarone; Anti-Arrhythmia Agents; Aortic Valve; Aortic Valve Stenosis; Aspartate Aminotransferases; Drug Interactions; Female; Fluorobenzenes; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Pyrimidines; Rosuvastatin Calcium; Sulfonamides | 2007 |